锦欣生殖(01951)于2026年5月14日发布公告，披露公司在香港联交所场内回购普通股股份，涉及回购数量3,292,000股，占已发行股本约0.12%。本次回购价格区间在每股2.37港元至2.40港元之间，合计支付金额约7,883,352.40港元，折合约788.34万港元。
公告显示，该等回购股份暂未被注销，截至2026年5月14日，公司已发行股本仍为2,705,044,043股，库藏股数为0股。回购授权由公司于2025年6月26日通过，授权可回购股份总数为274,470,604股。截至目前，公司已累计回购69,163,500股，占授权决议通过当日已发行股本约2.5199%。
公司在公告中确认，是次购回符合《香港联合交易所有限公司主板上市规则》等相关规定，未发生任何重大变动。公告由公司董事董阳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.